442例40岁以上慢性HBV携带者肝穿刺活组织检查的结果分析

孙海英; 王雅君; 王明; 张淑芹; 吕胜军; 陈慧

doi:10.3969/j.issn.1001-5256.2017.08.013

442例40岁以上慢性HBV携带者肝穿刺活组织检查的结果分析

DOI: 10.3969/j.issn.1001-5256.2017.08.013

吉林省肝胆病医院

基金项目:

吉林省卫生计生委科研计划项目(2013ZC044)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2427
- HTML全文浏览量: 47
- PDF下载量: 407
- 被引次数: 0
出版历程
- 收稿日期: 2017-03-08
- 出版日期: 2017-08-20

Liver biopsy results of chronic HBV carriers aged above 40 years: an analysis of 442 cases

Hepatology Hospital of Jilin Province

Research funding:

摘要

摘要:
目的观察40岁以上慢性HBV携带者肝脏组织学变化。方法收集2012年8月-2015年8月吉林省肝胆病医院年龄≥40岁慢性HBV携带者442例。所有患者在B型超声引导下采用快速穿刺法取肝组织进行检查,统计G2S2以上及肝硬化患者的比例,观察HBV感染病史肝功能、BMI、Fibro Scan与肝脏组织学变化的关系。计量资料组间比较采用t检验;采用相对危险度分析危险因素;采用Kappa分析进行一致性检验。结果 442例年龄≥40岁的慢性HBV携带者中,肝纤维化分级分期≥G2S2的患者占56.56%,肝硬化患者占20.14%。HBV感染病史的长短及BMI与肝纤维化程度有一定关联,病史超过10年[比值比（OR）=64.06,95%可信区间（95%CI）:33.72121.69,P<0.001]、BMI≥24 kg/m2（OR=6.93,95%CI:4.6410.35,P<0.001）为肝纤维化及肝硬化的危险因素。肝纤维化分级分期≥G2S2的患者与<G2S2的患者相比,ALT、AST、腺苷脱氨酶、GGT、ALP及前白蛋白水平差异均有统计...
- 肝炎病毒,乙型 /
- 活组织检查,针吸
Abstract:
Objective To observe the histological changes of the liver in chronic HBV carriers aged above 40 years. Methods A total of442 chronic HBV carriers aged above 40 years who underwent liver biopsy in Hepatology Hospital of Jilin Province from August 2012 to August 2015 were enrolled. Liver tissue samples were collected from all patients using ultrasound-guided rapid puncture, and the proportion of patients with grade ≥G2S2 liver fibrosis or liver cirrhosis was calculated. The association of medical history of HBV infection, liver function, body mass index ( BMI) and Fibro Scan with histological changes of the liver was analyzed. The t-test was used for comparison of continuous data between groups, relative risk ( RR) was used to analyze risk factors, and a Kappa analysis was used for consistency test. Results Of all 442 chronic HBV carriers aged ≥40 years, 56. 56% had grade ≥G2S2 liver fibrosis and 20. 14% had liver cirrhosis. The length of the medical history of HBV infection and BMI were correlated with the degree of liver fibrosis, and medical history > 10 years ( OR= 64. 06, 95% CI: 33. 72-121. 69, P < 0. 001) and BMI ≥24 ( OR = 6. 93, 95% CI: 4. 64-10. 35, P < 0. 001) were risk factors for liver fibrosis and cirrhosis. There were significant differences between grade < G2S2 liver fibrosis patients and grade ≥G2S2 liver fibrosis patients in the levels of alanine aminotransferase, aspartate aminotransferase, adenosine deaminase, gamma-glutamyl transpeptidase, alkaline phosphatase, and prealbumin ( t = 40. 00, 2. 16, 25. 35, 47. 73, 12. 62, and 13. 38, all P < 0. 05) . The consistency analysis of Fibro Scan and liver biopsy in the diagnosis of liver cirrhosis showed a Kappa value of 0. 76, suggesting that there was a good diagnostic consistency between these two methods. Conclusion Monitoring and management of chronic HBV carriers aged above 40 years should be taken seriously in clinical practice, and liver biopsy should be performed as soon as possible for those with ALT > 30 U/L and marked liver fibrosis suggested by Fibro Scan.
- hepatitis B virus /
- biopsy, needle

HTML全文

参考文献(15)

[1] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.

[2]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The programme of prevention and cure for viral hepatitis[J].Chin J Hepatol, 2000, 8 (6) :324-329. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.

[3]YANG Q, YAN YC, ZHANG MX, et al.Value of blood indicators in diagnosis of liver fibrosis in patients with chronic hepatitis B[J].World Chin J Dig, 2015, 23 (15) :2450-2456. (in Chinese) 杨晴, 颜迎春, 张明香, 等.血液指标在慢性乙型肝炎肝纤维化诊断中的价值[J].世界华人消化杂志, 2015, 23 (15) :2450-2456.

[4]ZENG DW, ZHANG JM, LIU YR, et al.A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity[J].Clin Res Hepatol Gastroenterol, 2014, 38 (6) :727-734.

[5]LIN CL, LIU CH, WANG CC, et al.Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B[J].J Clin Gastroenterol, 2015, 49 (8) :705-713.

[6]SIM SJ, CHEONG JY, CHO SW, et al.Efficacy of AST to platelet ratio index in predicting severe hepatic fibrosis and cirrhosis in chronic hepatitis B virus infection[J].Korean J Gastroenterol, 2005, 45 (5) :340-347.

[7]SHI MJ, ZHANG CZ, CHI XL, et al.Analysis of clinical highrisk factors for hepatitis B cirrhosis confirmed by liver biopsy[J].J Clin Hepatol, 2014, 30 (2) :149-152. (in Chinese) 施梅姐, 张朝臻, 池晓玲, 等.肝活组织检查确诊乙型肝炎肝硬化的临床高危因素分析[J].临床肝胆病杂志, 2014, 30 (2) :149-152.

[8]PARK SY, KANG KH, PARK JH, et al.Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis[J].Korean J Gastroenterol, 2004, 43 (4) :246-251.

[9]LI YB, DONG J, LIU YR, et al.Liver histopathological examination results of patients with chronic HBV infection and a persistently normal ALT level[J].J Pract Hepatol, 2011, 14 (3) :211-212. (in Chinese) 李友炳, 董菁, 刘豫瑞, 等.ALT持续正常的慢性HBV感染者肝组织病理学检查分析[J].实用肝脏病杂志, 2011, 14 (3) :211-212.

[10]LIU JJ, DING B, XU ZH, et al.The histological features and their clinical correlation in chronic HBV carriers and inactive HBs Ag carriers[J].Shenzhen J Integr Tradit Chin West Med, 2009, 19 (4) :216-219. (in Chinese) 刘建军, 丁波, 徐占浩, 等.慢性HBV与非活动性HBs Ag携带者肝组织学特点与临床关系[J].深圳中西医结合杂志, 2009, 19 (4) :216-219.

[11]ANGULO P, HUI JM, MARCHESINI G, et al.The NAFLD fibrosis score:a noninvasive system that identifies liver fibrosis in patients with NAFLD[J].Hepatology, 2007, 45 (4) :846-854.

[12]LOK AS, Mc MAHON BJ.Chronic hepatitis B[J].Hepatology, 2007, 45 (2) :507-539.

[13]MA LN, HE ZM, CAO ZH, et al.Relationship between liver pathology and clinical characters in HBV carriers[J].Chin J Hepatol, 2010, 18 (6) :433-436. (in Chinese) 马丽娜, 何智敏, 曹振环, 等.乙型肝炎病毒携带者的肝脏病理学与临床特征[J].中华肝脏病杂志, 2010, 18 (6) :433-436.

[14]CHEN N, SU MH, JIANG JN, et al.Liver pathology of middleaged chronic HBV carriers:an analysis of 160 cases[J].Guangdong Med J, 2013, 34 (5) :750-752. (in Chinese) 陈念, 苏明华, 江建宁, 等.中年慢性HBV携带者160例肝组织病理分析[J].广东医学, 2013, 34 (5) :750-752.

[15]XI XH.Association between the change in serum level of adenosine deaminase and hepatitis B[J].J Aerospace Med, 2013, 24 (1) :53-54. (in Chinese) 席小红.血清腺苷脱氨酶水平变化与病毒性乙型肝炎的关系探讨[J].航空航天医学杂志, 2013, 24 (1) :53-54.

施引文献

资源附件(0)

访问统计